Next Article in Journal
Characteristics and Management of Community-Acquired Pneumonia in the Era of Global Aging
Previous Article in Journal
Myeloperoxidase as an Active Disease Biomarker: Recent Biochemical and Pathological Perspectives
Article Menu
Issue 2 (June) cover image

Export Article

Open AccessReview
Med. Sci. 2018, 6(2), 34;

The Role of Adipokines in Intervertebral Disc Degeneration

Division of Orthopaedic Surgery, University of Manitoba, Winnipeg, MB R3A 1R9, Canada
Received: 9 February 2018 / Revised: 17 April 2018 / Accepted: 19 April 2018 / Published: 24 April 2018
(This article belongs to the Section Endocrinology and Metabolic Diseases)
Full-Text   |   PDF [1362 KB, uploaded 3 May 2018]   |  


Intervertebral disc degeneration (IDD) is an important cause of low back pain. Recent evidence suggests that in addition to abnormal and excessive mechanical loading, inflammation may be a key driver for both IDD and low back pain. Obesity, a known mechanical risk factor of IDD, is now increasingly being recognized as a systemic inflammatory state with adipokines being postulated as likely inflammatory mediators. The aim of this review was to summarize the current literature regarding the inflammatory role of adipokines in the pathophysiology of IDD. A systematic literature search was performed using the OVID Medline, EMBASE and PubMed databases to identify all studies assessing IDD and adipokines. Fifteen studies were included in the present review. Leptin was the most commonly assessed adipokine. Ten of 15 studies were conducted in humans; three in rats and two in both humans and rats. Studies focused on a variety of topics ranging from receptor identification, pathway analysis, genetic associations, and proteonomics. Currently, data from both human and animal experiments demonstrate significant effects of leptin and adiponectin on the internal milieu of intervertebral discs. However, future studies are needed to determine the molecular pathway relationships between adipokines in the pathophysiology of IDD as avenues for future therapeutic targets. View Full-Text
Keywords: disc degeneration; adipokines; leptin; adiponectin; resistin; spine; obesity disc degeneration; adipokines; leptin; adiponectin; resistin; spine; obesity

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Share & Cite This Article

MDPI and ACS Style

Sharma, A. The Role of Adipokines in Intervertebral Disc Degeneration. Med. Sci. 2018, 6, 34.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Med. Sci. EISSN 2076-3271 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top